Trials / Completed
CompletedNCT00092664
An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled "Factorial" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,104 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the lipid lowering effects of an investigational drug in patients with hypercholesterolemia (high cholesterol).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2003-09-01
- Completion
- 2003-09-01
- First posted
- 2004-09-28
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092664. Inclusion in this directory is not an endorsement.